Literature DB >> 2408968

Senile macular degeneration: the involvement of immunocompetent cells.

P L Penfold, M C Killingsworth, S H Sarks.   

Abstract

Senile macular degeneration (SMD) is a leading cause of legal blindness in western countries. The role of immunocompetent cells in the pathogenesis of this disease has not been widely recognised. In this work specimens were studied by electron microscopy to provide ultrastructural details of the role of immunocompetent cells in early, intermediate and late stages of the disease. Additionally, we have analysed the frequency and distribution of inflammatory cellular infiltrates using wax histology. The results illustrate the involvement of macrophage-series cells, fibroblasts, lymphocytes and mast cells in neovascularisation, atrophy of the retinal pigment epithelium and the breakdown of Bruch's membrane. These observations, together with previous clinicopathological studies, have led us to suggest that SMD has a chronic inflammatory component.

Entities:  

Mesh:

Year:  1985        PMID: 2408968     DOI: 10.1007/bf02150948

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  15 in total

1.  Ageing and degeneration in the macular region: a clinico-pathological study.

Authors:  S H Sarks
Journal:  Br J Ophthalmol       Date:  1976-05       Impact factor: 4.638

2.  Activated macrophages induce vascular proliferation.

Authors:  P J Polverini; P S Cotran; M A Gimbrone; E R Unanue
Journal:  Nature       Date:  1977-10-27       Impact factor: 49.962

Review 3.  Granulomatous inflammations.

Authors:  D L Boros
Journal:  Prog Allergy       Date:  1978

4.  Council Lecture. Drusen and their relationship to senile macular degeneration.

Authors:  S H Sarks
Journal:  Aust J Ophthalmol       Date:  1980-05

5.  Ageing changes in Bruch's membrane and their functional implications.

Authors:  C F Grindle; J Marshall
Journal:  Trans Ophthalmol Soc U K       Date:  1978-04

6.  Softening of drusen and subretinal neovascularization.

Authors:  S H Sarks; D Van Driel; L Maxwell; M Killingsworth
Journal:  Trans Ophthalmol Soc U K       Date:  1980-09

7.  Human monocyte stimulation of fibroblast growth by a soluble mediator(s).

Authors:  F DeLustro; G K Sherer; E C LeRoy
Journal:  J Reticuloendothel Soc       Date:  1980-12

8.  Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-derived growth factor.

Authors:  B M Martin; M A Gimbrone; E R Unanue; R S Cotran
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

9.  Immunologic and nonimmunologic activation of macrophages.

Authors:  J L Turk
Journal:  J Invest Dermatol       Date:  1980-05       Impact factor: 8.551

10.  Neovasculogenic ability of prostaglandins, growth factors, and synthetic chemoattractants.

Authors:  D BenEzra
Journal:  Am J Ophthalmol       Date:  1978-10       Impact factor: 5.258

View more
  98 in total

1.  Serum levels of antioxidants and age-related macular degeneration.

Authors:  N C Tsang; P L Penfold; P J Snitch; F Billson
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

Review 2.  Age-related macular degeneration: genetic and environmental factors of disease.

Authors:  Yuhong Chen; Matthew Bedell; Kang Zhang
Journal:  Mol Interv       Date:  2010-10

Review 3.  Age-related macular degeneration and the immune response: implications for therapy.

Authors:  Robert B Nussenblatt; Frederick Ferris
Journal:  Am J Ophthalmol       Date:  2007-08-15       Impact factor: 5.258

4.  Age-related macular degeneration: ultrastructural studies of the relationship of leucocytes to angiogenesis.

Authors:  P L Penfold; J M Provis; F A Billson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

5.  Macrophage polarization in the maculae of age-related macular degeneration: a pilot study.

Authors:  Xiaoguang Cao; Defen Shen; Mrinali M Patel; Jingsheng Tuo; T Mark Johnson; Timothy W Olsen; Chi-Chao Chan
Journal:  Pathol Int       Date:  2011-08-01       Impact factor: 2.534

6.  Angiogenesis in early choroidal neovascularization secondary to age-related macular degeneration.

Authors:  M C Killingsworth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-06       Impact factor: 3.117

7.  Fibronectin of the chorioretinal interface in the monkey: immunohistochemical and immunoelectron microscopic studies.

Authors:  T Ishibashi; T Kohno; N Sorgente; R Patterson; S J Ryan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

Review 8.  Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Authors:  S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Prog Retin Eye Res       Date:  2014-12-05       Impact factor: 21.198

9.  Asymmetry of disciform scarring in bilateral disease when one eye is treated with radiotherapy.

Authors:  P M Hart; D B Archer; U Chakravarthy
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

10.  Localization of complement 1 inhibitor (C1INH/SERPING1) in human eyes with age-related macular degeneration.

Authors:  Robert F Mullins; Elizabeth A Faidley; Heather T Daggett; Catherine Jomary; Andrew J Lotery; Edwin M Stone
Journal:  Exp Eye Res       Date:  2009-07-14       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.